OKYO Pharma (OKYO) Earnings Date & Reports

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OKYO is expected to report earnings to fall 33.33% to -1 cents per share on September 02

Q2'26

Est.

$-0.02

Q1'26

Beat

by $0.05

Q4'25

Est.

$-0.05

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.02

The last earnings report on June 03 showed earnings per share of -2 cents, beating the estimate of -7 cents. With 13.35K shares outstanding, the current market capitalization sits at 88.17M.

View a ticker or compare two or three

OKYO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days